James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $19.54 ($1.9M) on 2022-08-17, disclosed to the SEC on 2022-08-19.
Open-market sale of $1.9M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.54 | 15,954 | $312K | 16.2% |
| 2 | $19.54 | 15,954 | $312K | 16.2% |
| 3 | $19.09 | 34,046 | $650K | 33.8% |
| 4 | $19.09 | 34,046 | $650K | 33.8% |
| Total | $19.23 avg | 100,000 | $1.9M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |